Clinical Trials List
Protocol NumberCCTL019H2301
Completed
2020-08-01 - 2021-09-10
Phase III
Recruiting1
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- HSIN-AN HOU Division of General Internal Medicine
- Shang-Ju Wu Division of General Internal Medicine
- SONG-CHOU HSIEH 未分科
- 徐思淳 Division of Others
- Tai-Chung Huang Division of General Internal Medicine
- Huai-Hsuan Huang 未分科
- Chien-Chin Lin 未分科
- SHAN-CHI YU 未分科
- MING YAO Division of General Internal Medicine
- Sheng-chieh Chou 未分科
- CHENG-HONG TSAI 未分科
- 林明恩 未分科
- 袁章祖 未分科
- Jih-Luh Tang 未分科
- Chieh-Lung Cheng 未分科
- 田豐銘 未分科
- Wen-Chien Chou Division of Others -
- - - 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2-4 participants
-
Global
318 participants
